Stay updated on Semaglutide Effectiveness in Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.

Latest updates to the Semaglutide Effectiveness in Obesity Clinical Trial page
- CheckyesterdayChange DetectedExpanded the Locations section to include multiple US states (Alabama, California, Georgia, Kentucky, Louisiana, Maryland, Michigan, Nebraska, New York, North Carolina, Ohio, Tennessee, Texas, Virginia, Washington) and international sites (Denmark, Israel, the Netherlands, Portugal, Spain, Sweden, South Africa—Gauteng, KwaZulu-Natal, North West), indicating broader site availability.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedEditorial clarifications were added to the Publications section, noting that some publications are provided voluntarily by the person who enters information about the study and are auto-filled from PubMed, and the deletions reflect older wording, citing Revision: v3.2.0; the new text includes Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the site-wide government funding status banner that warned about potential delays and operating status.SummaryDifference0.2%

- Check51 days agoChange DetectedThe new screenshot shows the same study details with only minor formatting and layout tweaks, and no additions or deletions to core content such as the title, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange DetectedAdded a government-status notice and a new version tag (v3.2.0); removed the previous version tag (v3.1.0).SummaryDifference1%

- Check87 days agoChange DetectedUpdate adds a new version tag (v3.1.0) and removes several drug-safety topic sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), implying a content restructuring toward the new version with reduced emphasis on those topics.SummaryDifference0.2%

Stay in the know with updates to Semaglutide Effectiveness in Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.